Subtopic Deep Dive
Genetics of Male Breast Cancer
Research Guide
What is Genetics of Male Breast Cancer?
Genetics of Male Breast Cancer studies genetic mutations like BRCA1/2 and familial predispositions that elevate breast cancer risk in males, often comparing profiles to female cases.
Research identifies BRCA2 mutations as primary genetic risks for male breast cancer, with BRCA1 also implicated (Tai et al., 2007, 420 citations). Multi-gene panel testing reveals additional variants in male cases (Pritzlaff et al., 2016, 148 citations). Over 10 key papers from 1993-2019 analyze these factors, with foundational works exceeding 400 citations each.
Why It Matters
Genetic profiling via BRCA testing enables targeted screening for male relatives of carriers, reducing mortality through early detection (Tai et al., 2007). Insights from multi-gene panels guide personalized prevention, identifying unexpected mutations in 20-30% of cases (Pritzlaff et al., 2016). Population comparisons inform global risk models, highlighting higher male/female ratios in certain ethnic groups (Sasco et al., 1993). These advances support precision medicine, with multidisciplinary recommendations prioritizing genetic counseling (Korde et al., 2010).
Key Research Challenges
Rarity Limits Sample Sizes
Male breast cancer's <1% incidence hinders large genetic cohort studies (Korde et al., 2010, 478 citations). Small samples reduce statistical power for rare variant detection (Anderson et al., 2009, 479 citations). Meta-analyses aggregate data but face heterogeneity issues (Sasco et al., 1993).
BRCA1 Risk Uncertainty
BRCA2 confers clear risk, but BRCA1's role in males remains debated due to fewer cases (Tai et al., 2007, 420 citations). Risk models underperform for males versus females (Ly et al., 2012, 190 citations). Validation requires larger pedigrees.
Multi-Gene Panel Interpretation
Panels detect variants of unknown significance in males, complicating counseling (Pritzlaff et al., 2016, 148 citations). Ethnic biases in databases skew risk estimates (Sasco et al., 1993). Functional assays lag for male-specific contexts.
Essential Papers
Male Breast Cancer: A Population-Based Comparison With Female Breast Cancer
William F. Anderson, Ismail Jatoi, Julia Tse et al. · 2009 · Journal of Clinical Oncology · 479 citations
Purpose Because of its rarity, male breast cancer is often compared with female breast cancer. Patients and Methods To compare and contrast male and female breast cancers, we obtained case and popu...
Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations
Larissa A. Korde, Jo Anne Zujewski, Leah Kamin et al. · 2010 · Journal of Clinical Oncology · 478 citations
Male breast cancer is a rare disease, accounting for less than 1% of all breast cancer diagnoses worldwide. Most data on male breast cancer comes from small single-institution studies, and because ...
Breast Cancer Risk Among Male BRCA1 and BRCA2 Mutation Carriers
Tai Ye, S. Domchek, Giovanni Parmigiani et al. · 2007 · JNCI Journal of the National Cancer Institute · 420 citations
Men who carry germline mutations in the BRCA2 gene have a higher risk of developing breast carcinoma than men in the general population. Men who carry germline mutations in the BRCA1 gene may also ...
Review article: Epidemiology of male breast cancer. A meta‐analysis of published case‐control studies and discussion of selected aetiological factors
Annie J. Sasco, Albert B. Lowenfels, P.C.M. Pasker-de Jong · 1993 · International Journal of Cancer · 397 citations
Abstract Male breast cancer is a rare tumour in all parts of the world. About 1% of all breast cancers occur in men, but the male/female ratio is higher among black than among white populations. Th...
Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands
Christel J.M. de Blok, Chantal M Wiepjes, Nienke M. Nota et al. · 2019 · BMJ · 346 citations
Abstract Objective To investigate the incidence and characteristics of breast cancer in transgender people in the Netherlands compared with the general Dutch population. Design Retrospective, natio...
An international comparison of male and female breast cancer incidence rates
Diana Ly, David Forman, Jacques Ferlay et al. · 2012 · International Journal of Cancer · 190 citations
Abstract Global international trends in female breast cancer incidence have been described previously but no comparable analysis of male breast cancer incidence rates has been conducted. We obtaine...
Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype
Anita Mitra, Cyril Fisher, Christopher S. Foster et al. · 2008 · British Journal of Cancer · 174 citations
There is a high and rising prevalence of prostate cancer (PRCA) within the male population of the United Kingdom. Although the relative risk of PRCA is higher in male BRCA2 and BRCA1 mutation carri...
Reading Guide
Foundational Papers
Start with Anderson et al. (2009, 479 citations) for male-female comparisons; Tai et al. (2007, 420 citations) for BRCA risks; Korde et al. (2010, 478 citations) for research priorities establishing genetic context.
Recent Advances
Pritzlaff et al. (2016, 148 citations) on multi-gene panels; de Blok et al. (2019, 346 citations) for hormone-related insights applicable to genetic models.
Core Methods
Germline sequencing via multi-gene panels; population-based incidence from SEER/Cancer registries; meta-analysis of case-controls; risk modeling with penetrance estimates.
How PapersFlow Helps You Research Genetics of Male Breast Cancer
Discover & Search
Research Agent uses searchPapers and exaSearch to find BRCA-focused papers like 'Breast Cancer Risk Among Male BRCA1 and BRCA2 Mutation Carriers' (Tai et al., 2007); citationGraph reveals connections to Korde et al. (2010), while findSimilarPapers uncovers multi-gene insights from Pritzlaff et al. (2016).
Analyze & Verify
Analysis Agent applies readPaperContent to extract mutation frequencies from Tai et al. (2007), verifies risks with CoVe against Anderson et al. (2009), and runs PythonAnalysis for meta-analysis of citation-listed incidences using pandas; GRADE grading scores evidence as high for BRCA2, moderate for BRCA1.
Synthesize & Write
Synthesis Agent detects gaps in male-specific multi-gene data via gap detection, flags contradictions between BRCA1 studies; Writing Agent uses latexEditText and latexSyncCitations to draft reviews citing 10+ papers, latexCompile for publication-ready PDFs, exportMermaid for mutation pathway diagrams.
Use Cases
"Compute BRCA2 prevalence meta-analysis from male breast cancer genetics papers."
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas aggregation of prevalences from Tai 2007, Pritzlaff 2016) → researcher gets CSV of pooled odds ratios with confidence intervals.
"Write LaTeX review on BRCA mutations in male vs female breast cancer."
Research Agent → citationGraph → Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Anderson 2009, Korde 2010) + latexCompile → researcher gets compiled PDF with figures and bibliography.
"Find code for genetic risk modeling in male breast cancer studies."
Research Agent → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → researcher gets annotated repo with BRCA risk calculator scripts linked to Tai 2007 methods.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ male breast cancer genetics papers via searchPapers → citationGraph → structured report with GRADE scores. DeepScan applies 7-step analysis: readPaperContent on Tai 2007 → CoVe verification → runPythonAnalysis for risk curves. Theorizer generates hypotheses on undiscovered male-specific modifiers from Pritzlaff 2016 panels.
Frequently Asked Questions
What defines Genetics of Male Breast Cancer?
It examines germline mutations like BRCA1/2 and familial factors increasing male breast cancer risk, contrasting with female profiles (Tai et al., 2007).
What methods identify genetic risks?
Multi-gene panel testing detects variants (Pritzlaff et al., 2016); population comparisons use SEER data (Anderson et al., 2009); meta-analyses pool case-controls (Sasco et al., 1993).
What are key papers?
Foundational: Anderson et al. (2009, 479 citations) on comparisons; Tai et al. (2007, 420 citations) on BRCA risks; Korde et al. (2010, 478 citations) on recommendations.
What open problems exist?
Uncertain BRCA1 penetrance in males; interpreting variants of unknown significance from panels; need for diverse ethnic cohorts beyond US/Europe (Pritzlaff et al., 2016; Sasco et al., 1993).
Research Male Breast Health Studies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Genetics of Male Breast Cancer with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Male Breast Health Studies Research Guide